NYSE : FBIN
-$0.37 (-0.74%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-14 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-07-10 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-06-30 | Truist Securities | Hold | Buy | Upgrade |
| 2026-06-30 | Evercore ISI Group | In Line | In Line | Maintain |
| 2026-05-15 | JP Morgan | Neutral | Neutral | Maintain |
| 2026-05-11 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-05-08 | UBS | Buy | Buy | Maintain |
| 2026-05-08 | Evercore ISI Group | In Line | In Line | Maintain |
| 2026-05-08 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-08 | Truist Securities | Hold | Hold | Maintain |
| 2026-04-21 | Baird | Neutral | Neutral | Maintain |
| 2026-04-20 | BMO Capital | Market Perform | Market Perform | Maintain |
| 2026-04-20 | B of A Securities | Underperform | Underperform | Maintain |
| 2026-04-13 | Evercore ISI Group | In Line | In Line | Maintain |
| 2026-04-08 | Barclays | Equal Weight | Equal Weight | Maintain |
| 2026-02-17 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-02-17 | BMO Capital | Market Perform | Market Perform | Maintain |
| 2026-02-13 | Zelman & Assoc | Outperform | Neutral | Downgrade |
| 2026-02-13 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2026-02-13 | Barclays | Overweight | Equal Weight | Downgrade |
| 2026-01-15 | Barclays | Overweight | Overweight | Maintain |